EP 1257266 A1 20021120 - INTRAVENOUS CARNITINE FOR THE TREATMENT OF CHRONIC URAEMIC PATIENTS UNDERGOING PERIODICAL DIALYSIS
Title (en)
INTRAVENOUS CARNITINE FOR THE TREATMENT OF CHRONIC URAEMIC PATIENTS UNDERGOING PERIODICAL DIALYSIS
Title (de)
INTRAVENÖSE GABE VON CARNITIN ZUR BEHANDLUNG VON PERIODISCH DIALYSIERTEN PATIENTEN MIT CHRONISCHER NIERENINSUFFIZIENZ
Title (fr)
CARNITINE PAR INTRAVEINEUSE DESTINEE AU TRAITEMENT DE PATIENTS SOUFFRANT D'UREMIE CHRONIQUE SOUMIS A UNE DIALYSE PERIODIQUE
Publication
Application
Priority
- IT 0100012 W 20010115
- US 17662900 P 20000119
- US 18632800 P 20000302
Abstract (en)
[origin: WO0152836A1] The method for the treatment of chronic uraemic patients undergoing periodical dialysis is useful for preventing and/or treating carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. The method according to the present invention comprises administering an effective dose of carnitine intravenously into the venous return line after each dialysis session.
IPC 1-7
IPC 8 full level
A61K 31/205 (2006.01); A61P 7/08 (2006.01)
CPC (source: EP)
A61K 31/205 (2013.01); A61P 7/08 (2017.12)
Citation (search report)
See references of WO 0152836A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0152836 A1 20010726; AU 3050201 A 20010731; CA 2381187 A1 20010726; CA 2381187 C 20090602; EP 1257266 A1 20021120
DOCDB simple family (application)
IT 0100012 W 20010115; AU 3050201 A 20010115; CA 2381187 A 20010115; EP 01902636 A 20010115